Bruker (BRKR) reported Q1 non-GAAP earnings Wednesday of $0.47 per diluted share, down from $0.53 a year earlier.
Analysts polled by FactSet expected $0.44.
Revenue for the quarter ended March 31 was $801.4 million, up from $721.7 million a year earlier. Analysts surveyed by FactSet expected $768.5 million.
The company, citing "US policy changes and tariff headwinds," said it now expects full-year 2025 non-GAAP EPS of $2.40 to $2.48 on revenue of $3.48 billion to $3.55 billion, compared with prior guidance of non-GAAP EPS of $2.67 to $2.72 on revenue of $3.47 billion to $3.54 billion.
Analysts surveyed by FactSet expect non-GAAP of $2.59 on revenue of $3.48 billion.
Bruker shares were down more than 3% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。